❌

Normal view

Received β€” 10 September 2026 ⏭ Oncogenesis - nature.com science feeds

CD44v5 promotes triple-negative breast cancer cisplatin resistance by enhancing IL-4/IL-4RΞ±/STAT3 pathway and stabilizing membranous SLC7A11

Oncogenesis, Published online: 21 August 2026; doi:10.1038/s41389-026-00650-0

CD44v5 promotes triple-negative breast cancer cisplatin resistance by enhancing IL-4/IL-4RΞ±/STAT3 pathway and stabilizing membranous SLC7A11
❌